Allied Market Research

2024

Tick-borne Encephalitis Vaccine Market

Tick-borne Encephalitis Vaccine Market Size, Share, Competitive Landscape and Trend Analysis Report by Type of Vaccine, by Age Group, by End Use and by Distribution Channel : Opportunity Analysis and Industry Forecast, 2023-2032

LS : Other

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

The global Tick-borne encephalitis vaccine market report covers market size, share, and growth rate (CAGR %) for various segments at regional and country levels. Along with various market dynamics such as drivers, restraints, market trends, and opportunities, the market overview section of the report highlights the qualitative aspect of the market. Furthermore, the section covers the market snapshot and key findings, in terms of investment opportunity and market overview. The report further includes a detailed competitive landscape comprising comprehensive profiles of leading players. The top players are assessed depending on their revenue size, market share, geographical presence, recent developments & strategic initiatives, and overall contribution to the market.

Key players identified in this report are GlaxoSmithKline plc, Serum Institute of India Private Limited, Sanofi, Merck and Co., Inc., Pfizer, Inc., FivePrime Therapeutics, Inc., Valneva PLC, Novavax, Inc., Wyeth, BAXTER

Market Snapshot

Report Metric

Details

Market size available for the years

2032

Base year considered

2023

Forecast period

2024

Forecast unit

Value (USD)

Segments covered

by type of vaccine, by age group, by end use, by distribution channel

Companies covered

GlaxoSmithKline plc, Serum Institute of India Private Limited, Sanofi, Merck and Co., Inc., Pfizer, Inc., FivePrime Therapeutics, Inc., Valneva PLC, Novavax, Inc., Wyeth, BAXTER

Key Inclusions

  • Qualitative as well as quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

  • Analysis at regional and country level, which highlights the consumption of the product or service in the different geographies.

  • Extensive company profiles section, which includes different pointers such as company overview, key executive, company snapshot, business performance, product/service portfolio, R&D spending, and key strategies and developments of the major market players.

  • The current and estimated market outlook of the Tick-borne encephalitis vaccine market with respect to recent developments which include analysis of drivers, market trends, and growth opportunities

  • Free 20% customization and post-sales support

Tick-borne Encephalitis Vaccine Market Report Highlights

Aspects Details
icon_5
By Type of Vaccine
  • Conjugate Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
icon_6
By Age Group
  • Infants
  • Children
  • Adults
icon_7
By End Use
  • Hospitals / Clinics
  • Research Institutes / Laboratories
icon_8
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_10
Key Market Players

Sanofi, Serum Institute of India Private Limited, Novavax, Wyeth, GlaxoSmithKline plc, Merck and Co., Valneva PLC, FivePrime Therapeutics, Pfizer, BAXTER

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Tick-borne Encephalitis Vaccine Market

Opportunity Analysis and Industry Forecast, 2023-2032